NF2 and neoplasm: Analysis of The Cancer Genome Atlas (TCGA) PDAC cohort revealed that lower NF2 expression correlates with a poorer prognosis, especially in patients with a classical subtype (21), suggesting a tumor-suppressive role for this gene (Figure 2A).